Abstract: Misleading visualizations pose a significant challenge to accurate data interpretation. While recent research has explored the use of Large Language Models (LLMs) for detecting such ...

Amazon has updated its Dash Cart and on Wednesday released details about several new features. The company said it based the enhancements on customer feedback. Amazon rolled out the updated Dash Cart ...

Public trust in the media and in data has been undercut by information overload, relentless social media cycles, and targeted influence campaigns. Whether driven by politics, social movements, or ...

This coal plant in central Pennsylvania, once the largest in the state, was shuttered in 2023 after powering the region for over 50 years. Earlier this year, wrecking crews blasted the plant’s cooling ...

Advanced data visualization and analytics have become central to enterprise IT strategies as organizations face rapid data growth from cloud services, software-as-a-service applications, edge devices, ...

LONDON, Nov 10 (Reuters) - The return of U.S. economic data when Washington reopens may do little to clear up a macro picture that is clouded by the dash for artificial intelligence and compounded by ...

DoorDash reported third-quarter earnings that missed analyst expectations. The food delivery platform said it expects to spend "several hundred million dollars" on new initiatives and development in ...

Interactive Data and Forewarn were hit with a privacy class action on Oct. 30 in Florida Southern District Court. The suit, brought by Bursor & Fisher on behalf of Colorado residents, accuses the data ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. In this episode, Thomas Betts chats with ...

A back-to-roots trade is emerging as market participants take notice of the privacy corners of the crypto ecosystem, bringing attention back to what dominated much of the 2017-18 bull market cycle.

Arthrosi Therapeutics has raised $153 million to bankroll its bid to clout gout. The series E financing gives the biotech the financial firepower to deliver data from two phase 3 trials next year. San ...